A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Teclison Ltd.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Rezolute
Exelixis
Institute for Clinical and Experimental Medicine
Orano Med LLC
Amgen
Instituto do Cancer do Estado de São Paulo
Vastra Gotaland Region
Fundación de investigación HM
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Providence Health & Services
National Cancer Institute (NCI)
RayzeBio, Inc.
Melanoma and Skin Cancer Trials Limited
National Health Research Institutes, Taiwan
National Institutes of Health Clinical Center (CC)
ITM Solucin GmbH
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Turning Point Therapeutics, Inc.
RayzeBio, Inc.
Boston Scientific Corporation
Melanoma and Skin Cancer Trials Limited
National Institutes of Health Clinical Center (CC)
University Health Network, Toronto
M.D. Anderson Cancer Center
Crinetics Pharmaceuticals Inc.
University of Wisconsin, Madison
Centre Oscar Lambret
Stanford University
University of California, San Francisco
M.D. Anderson Cancer Center
Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc.
M.D. Anderson Cancer Center
Hoffmann-La Roche
Grupo Espanol de Tumores Neuroendocrinos
Columbia University
Olivia Newton-John Cancer Research Institute
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Cedars-Sinai Medical Center
University of Florida
University of Michigan Rogel Cancer Center